• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 11
      Medical treatment research in Leeds secures £140m in external funding, figures reveal - 3 day(s) ago

      Research into cutting-edge medical treatments for patients in Leeds has generated £140m in external funding over the last five years, new figures have revealed.

      Source: www.yorkshirepost.co.uk
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        I'm so excited for the 4th Annual @LeedsHospitals Research & Innovation Conference in #Leeds!😀 🌟Looking forward to the highlight of the @LTHTResearch calendar! 👉🏼https://t.co/Oes7wZwxJ9 👉🏼https://t.co/o8HYfskmOa

    • Mashup Score: 8
      EULAR Abstract Archive - 29 day(s) ago

      Keywords: Remission, Anti-Inflammatory Agents, Non-Steroidal, Safety 1 Department of Rheumatology, Medical Faculty of Heinrich-Heine University, D ü sseldorf, Germany 2 Hiller Research Center, University Hospital D ü sseldorf, Medical Faculty of Heinrich-Heine University, D ü sseldorf, Germany 3 Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, and Fraunhofer Cluster of Excellence for Immune Mediated Diseases CIMD, Frankfurt am Main, Germany 4 Department of Internal Medicine and

      Source: scientific.sparx-ip.net
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        #Blinatumomab may offer potential for induction of remission in anti-synthetase syndrome #myositis OP0297 by @ChristinaDusing #EULAR2025 👉🏼https://t.co/ruvXZIl1aF https://t.co/3D95YVZBbB

    • Mashup Score: 8
      How one city has taken the lead in healthcare innovation - 1 month(s) ago

      As technology enables more targeted treatment, healthcare systems face questions about sustainability, access, and how to embed innovation at scale, explains Dr Ai Lyn Tan

      Source: www.hsj.co.uk
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        🗨️Realising potential of personalised medicine demands collaboration: clinicians, researchers, policymakers We must sustain momentum to unlock power of tailored healthcare 🌟#Leeds leads the way @LTHTResearch @LeedsHospitals 👉🏼https://t.co/35JJfoL0mw 👉🏼https://t.co/0GvRjMkxFa

    • Mashup Score: 2
      Why do patients take part in research? An updated overview of systematic reviews of psychosocial barriers and facilitators - Trials - 1 month(s) ago

      Background Efficient, equitable health research depends on understanding why people decide to take part. The aims of this overview were to update the version published in 2020, identifying psychosocial influences on participation and mapping them to recruitment research and psychological theory. Methods Searches were undertaken in February 2024. Qualitative, quantitative, and mixed-methods systematic reviews were identified, without language or date limits. Methodological quality was rated using AMSTAR-2, and low-quality reviews were excluded. Barriers and facilitators were identified inductively and mapped to the Theoretical Domains Framework (TDF) and COM-B model, and to empirical recruitment research. Results The update included 70 reviews, including 44 new reviews, covering a breadth of populations and settings, and drawing on 1940 primary studies (1428 unique). We identified 15 facilitators, most commonly: altruism, potential for personal benefit and trust. Incentives and convenie

      Source: trialsjournal.biomedcentral.com
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        Why do #patients take part in #research? Facilitators ▶️Altruism ▶️Potential for personal benefit ▶️Trust ▶️Incentives ▶️Convenient, low-burden research ▶️Feeling valued Barriers ▶️Perceived risk ▶️Practical difficulties ▶️Distrust of researchers 👉🏽https://t.co/iKwhPAjppG https://t.co/l3huhCKJNL

    • Mashup Score: 20
      Bullhead Sign in SAPHO Syndrome - 1 month(s) ago

      A local male in his mid-40s had a 10-year history of pain over both clavicles and sternoclavicular joints. In May 2023, he visited the outpatient rheumatology clinic where physical examination demonstrated enlarged clavicles (Figure 1A) (arrows) but no cutaneous manifestations. Laboratory tests disclosed elevated erythrocyte sedimentation rate (84 mm/h; reference, <16 mm/h), increased C-reactive protein levels (113 mg/L; reference, <8 mg/L), absent human leucocyte antigen-B27, and negative culture results.

      Source: www.mayoclinicproceedings.org
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        RT @DrAiLynTan: Bullhead Sign in #SAPHO Syndrome ▶️Synovitis, ▶️Acne ▶️Pustulosis ▶️Hyperostosis ▶️Osteitis 👉🏽https://t.co/ownI4Q543w via…

    • Mashup Score: 3
      Medical breakthroughs: The research journey - Leeds Teaching Hospitals NHS Trust - 1 month(s) ago

      Medical Breakthroughs: The Research Journey is a new podcast from Leeds Teaching Hospitals NHS Trust (LTHT) sharing the powerful stories behind some of the UK’s most significant medical advances.

      Source: www.leedsth.nhs.uk
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        I am so excited about this new Research Podcast from @LeedsHospitals!😀 👉🏽https://t.co/6JpD6O9iJW https://t.co/0hIcPzPMtV

    • Mashup Score: 3
      Welcome to the latest edition of the Research and Innovation newsletter - 1 month(s) ago

      Dr Ai Lyn Tan Research and Innovation (R&I) Director Dear colleagues, Since our last edition, we have had lots of exciting updates and success stories to share. To catch up on everything happening across R&I, head over to the news section of the R&I webpage.

      Source: www.linkedin.com
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        Every time we publish this, I'm in awe of the achievements, the growing areas of medical advancement, with so many patients benefiting from #research & #innovation in #Leeds @LeedsHospitals👏🏼 🫶🏼Thank you to all researchers, collaborators & patients! 👉🏽https://t.co/Dkre5f5b4Z https://t.co/DSOz2sFtUl

    • Mashup Score: 0
      Why do we keep telling introverts to speak up? But never ask extroverts… | Peter Sorgenfrei | 707 comments - 2 month(s) ago

      Why do we keep telling introverts to speak up? But never ask extroverts to listen more? This double standard in professional settings needs to stop. Here’s the truth about introverts in business: → They process deeply before speaking → They notice subtleties others miss → They bring calm to chaos → They create space for others to think But instead of leveraging these strengths, we: • Push them to “speak up more” • Label them as “too quiet” • Mistake their reflection for hesitation The real opportunity? Teaching extroverts to: → Create space for quiet voices → Value thoughtful pauses → Recognize that leadership has many sounds Great teams need both energies. Great leaders understand this balance. What matters isn’t the volume of your voice, but the value of your contribution. Are you creating space for both styles to thrive? | 707 comments on LinkedIn

      Source: www.linkedin.com
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        Are you creating space for both introverts & extroverts to thrive? Teach #extroverts to ✅Create space for quiet voices ✅Value thoughtful pauses ✅Recognise #leadership has many sounds #Introverts 👉🏼Process deeply before speaking 👉🏼Bring calm to chaos https://t.co/9t5mvQWevy

    • Mashup Score: 4
      Shaunna's “living fully with cancer”: Climbing and running the Everest marathon - 2 month(s) ago

      Help Shaunna Burke raise money to support Macmillan Cancer Support

      Source: www.justgiving.com
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        This is incredible! Read @shaunna_burke's inspiring story 👉🏽https://t.co/zuOMdboXMj 💪🏽Good luck Shaunna! https://t.co/77m1Ty7QZb

    • Mashup Score: 208
      Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections - 2 month(s) ago

      Background: In 14 randomized controlled studies to date, a procalcitonin (PCT)-based algorithm has been proven to markedly reduce the use of antibiotics along with an unimpaired high safety and low complication rates in patients with lower respiratory tract infections (LRTIs). However, compliance with the algorithm and safety out of controlled study conditions has not yet been sufficiently investigated. Methods: We performed a prospective international multicenter observational post-study surveillance of consecutive adults with community-acquired LRTI in 14 centers (Switzerland (n = 10), France (n = 3) and the United States (n = 1)). Results: Between September 2009 and November 2010, 1,759 patients were enrolled (median age 71; female sex 44.4%). 1,520 (86.4%) patients had a final diagnosis of LRTI (community-acquired pneumonia (CAP), 53.7%; acute exacerbation of chronic obstructive pulmonary disease (AECOPD), 17.1%; and acute bronchitis, 14.4%). Compliance with the PCT-guided therapy

      Source: www.mdpi.com
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	DrAiLynTan
        DrAiLynTan

        RT @drsthanus: Algorithm for procalcitonin (PCT)-guided antibiotic therapy. https://t.co/6RSJzKdh8e https://t.co/ixHoFE681s

    Load More

    Dr Ai Lyn Tan

    @DrAiLynTan

    Associate Professor. Rheumatologist. Research: arthritis, muscle, MRI, ultrasound @parkrunUK #SocialMedia Ambassador. pro-#physicalactivity. I run @AiLyn_Runner

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings